- Home
- GDTC vs OPAD Comparison
GDTC vs OPAD Comparison
Compare GDTC & OPAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- OPAD
- Stock Information
- Founded
- GDTC 2018
- OPAD 2015
- Country
- GDTC Singapore
- OPAD United States
- Employees
- GDTC N/A
- OPAD N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- OPAD Real Estate
- Sector
- GDTC Health Care
- OPAD Finance
- Exchange
- GDTC Nasdaq
- OPAD Nasdaq
- Market Cap
- GDTC 21.5M
- OPAD 25.3M
- IPO Year
- GDTC 2023
- OPAD N/A
- Fundamental
- Price
- GDTC $1.89
- OPAD $1.36
- Analyst Decision
- GDTC Buy
- OPAD Hold
- Analyst Count
- GDTC 1
- OPAD 5
- Target Price
- GDTC $5.00
- OPAD $2.38
- AVG Volume (30 Days)
- GDTC 18.1K
- OPAD 2.3M
- Earning Date
- GDTC 01-01-0001
- OPAD 08-04-2025
- Dividend Yield
- GDTC N/A
- OPAD N/A
- EPS Growth
- GDTC N/A
- OPAD N/A
- EPS
- GDTC N/A
- OPAD N/A
- Revenue
- GDTC $368,838.00
- OPAD $794,159,000.00
- Revenue This Year
- GDTC $5.37
- OPAD N/A
- Revenue Next Year
- GDTC N/A
- OPAD $40.79
- P/E Ratio
- GDTC N/A
- OPAD N/A
- Revenue Growth
- GDTC N/A
- OPAD N/A
- 52 Week Low
- GDTC $1.20
- OPAD $0.91
- 52 Week High
- GDTC $4.05
- OPAD $5.13
- Technical
- Relative Strength Index (RSI)
- GDTC 37.08
- OPAD 44.26
- Support Level
- GDTC $1.85
- OPAD $1.91
- Resistance Level
- GDTC $1.95
- OPAD $4.95
- Average True Range (ATR)
- GDTC 0.10
- OPAD 0.72
- MACD
- GDTC -0.02
- OPAD -0.10
- Stochastic Oscillator
- GDTC 28.00
- OPAD 1.37
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About OPAD Offerpad Solutions Inc.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.